Giuseppe Cicero
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 19
- Cancer Treatment and Pharmacology 18
- Immunology top 5%
- Immune Cell Function and Interaction 7
- Cancer Research top 5%
- Breast Cancer Treatment Studies 6
-
- Gastric Cancer Management and Outcomes 8
- Lung Cancer Treatments and Mutations 8
- Prostate Cancer Treatment and Research 8
-
- Genetic factors in colorectal cancer 8
- Co-authors
- Antonio RussoFrancesco DieliViviana BazanSerena MeravigliaGiuseppe BronteNadia CaccamoDaniele FanaleFabio Fulfaro
- Cited by
- OncologyImmunologyCancer Research
In The Last Decade
Giuseppe Cicero
95 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 121
- Oncology 1.5k
- Immunology 892
- Cancer Research 547
- Pulmonary and Respiratory Medicine 527
- Pathology and Forensic Medicine 253
Countries citing papers authored by Giuseppe Cicero
This map shows the geographic impact of Giuseppe Cicero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Cicero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Cicero more than expected).
Fields of papers citing papers by Giuseppe Cicero
This network shows the impact of papers produced by Giuseppe Cicero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Cicero. The network helps show where Giuseppe Cicero may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Giuseppe Cicero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 3 | |
| 4 | 2021 | 28 | |
| 5 | Uneasiness Body Image and Psychological Distress in Women with Breast Cancer in Chemotherapy Treatment | 2021 | 1 |
| 6 | 2020 | 4 | |
| 7 | Nab-paclitaxel in pretreated metastatic breast cancer: evaluation of activity, safety, and quality of life | 2019 | 1 |
| 8 | 2019 | 15 | |
| 9 | 2018 | 11 | |
| 10 | 2018 | 18 | |
| 11 | 2018 | 9 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 4 | |
| 14 | 2015 | 95 | |
| 15 | 2014 | 3 | |
| 16 | 2014 | 12 | |
| 17 | 2014 | 2 | |
| 18 | 2013 | 5 | |
| 19 | Docetaxel plus prednisone in patients with metastatic hormone-refractory prostate cancer: an Italian clinical experience. | 2011 | 1 |
| 20 | 2007 | 404 |
About Giuseppe Cicero
Giuseppe Cicero is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 97 papers that have together received 2.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (19 papers), Cancer Treatment and Pharmacology (18 papers), Gastric Cancer Management and Outcomes (8 papers), Genetic factors in colorectal cancer (8 papers), Lung Cancer Treatments and Mutations (8 papers), Prostate Cancer Treatment and Research (8 papers), Immune Cell Function and Interaction (7 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Oncology (1.5k citations), Immunology (892 citations) and Cancer Research (547 citations). Giuseppe Cicero has collaborated with scholars based in Italy, Argentina and Belgium. Frequent co-authors include Antonio Russo, Francesco Dieli, Viviana Bazan, Serena Meraviglia, Giuseppe Bronte, Nadia Caccamo, Daniele Fanale, Fabio Fulfaro, Adrian Hayday and David Vermijlen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.